Mirati Therapeutics, Inc. Quarterly Operating Income (Loss) in USD from Q2 2012 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Mirati Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2012 to Q3 2023.
  • Mirati Therapeutics, Inc. Operating Income (Loss) for the quarter ending September 30, 2023 was -$172M, a 7.72% increase year-over-year.
  • Mirati Therapeutics, Inc. Operating Income (Loss) for the twelve months ending September 30, 2023 was -$765M, a 2.68% decline year-over-year.
  • Mirati Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$760M, a 32.5% decline from 2021.
  • Mirati Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$573M, a 55.2% decline from 2020.
  • Mirati Therapeutics, Inc. annual Operating Income (Loss) for 2020 was -$369M, a 66.3% decline from 2019.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2023 -$765M -$172M +$14.4M +7.72% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-06
Q2 2023 -$779M -$187M -$10.1M -5.68% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-08
Q1 2023 -$769M -$194M -$9.61M -5.21% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-09
Q4 2022 -$760M -$212M -$14.6M -7.43% Oct 1, 2022 Dec 31, 2022 10-K 2023-02-28
Q3 2022 -$745M -$186M -$107M -135% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-06
Q2 2022 -$638M -$177M -$13M -7.93% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 -$625M -$184M -$51.8M -39.1% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 -$573M -$197M -$90.7M -85.3% Oct 1, 2021 Dec 31, 2021 10-K 2022-02-28
Q3 2021 -$482M -$79.5M +$9.18M +10.4% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 -$492M -$164M -$79.3M -93.5% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-03
Q1 2021 -$412M -$132M -$42.9M -48% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
Q4 2020 -$369M -$106M -$31.7M -42.5% Oct 1, 2020 Dec 31, 2020 10-K 2022-02-28
Q3 2020 -$338M -$88.7M -$31.6M -55.4% Jul 1, 2020 Sep 30, 2020 10-K 2022-02-28
Q2 2020 -$306M -$84.9M -$37.2M -78.1% Apr 1, 2020 Jun 30, 2020 10-K 2022-02-28
Q1 2020 -$269M -$89.5M -$46.7M -109% Jan 1, 2020 Mar 31, 2020 10-K 2022-02-28
Q4 2019 -$222M -$74.6M -$45M -152% Oct 1, 2019 Dec 31, 2019 10-K 2021-02-25
Q3 2019 -$177M -$57.1M -$28.1M -97.2% Jul 1, 2019 Sep 30, 2019 10-K 2021-02-25
Q2 2019 -$149M -$47.6M -$19M -66.2% Apr 1, 2019 Jun 30, 2019 10-K 2021-02-25
Q1 2019 -$130M -$42.8M -$27.4M -179% Jan 1, 2019 Mar 31, 2019 10-K 2021-02-25
Q4 2018 -$103M -$29.7M -$11.4M -62.8% Oct 1, 2018 Dec 31, 2018 10-K 2020-02-26
Q3 2018 -$91.2M -$28.9M -$12.3M -74.3% Jul 1, 2018 Sep 30, 2018 10-K 2020-02-26
Q2 2018 -$78.8M -$28.7M -$10.1M -54% Apr 1, 2018 Jun 30, 2018 10-K 2020-02-26
Q1 2018 -$68.8M -$15.3M +$2.74M +15.2% Jan 1, 2018 Mar 31, 2018 10-K 2020-02-26
Q4 2017 -$71.5M -$18.2M +$1.63M +8.19% Oct 1, 2017 Dec 31, 2017 10-K 2019-02-28
Q3 2017 -$73.2M -$16.6M +$2.98M +15.2% Jul 1, 2017 Sep 30, 2017 10-K 2019-02-28
Q2 2017 -$76.1M -$18.6M +$3.61M +16.2% Apr 1, 2017 Jun 30, 2017 10-K 2019-02-28
Q1 2017 -$79.8M -$18.1M +$4.03M +18.2% Jan 1, 2017 Mar 31, 2017 10-K 2019-02-28
Q4 2016 -$83.8M -$19.9M -$1.37M -7.38% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-08
Q3 2016 -$82.4M -$19.6M -$857K -4.58% Jul 1, 2016 Sep 30, 2016 10-K 2018-03-08
Q2 2016 -$81.6M -$22.2M -$6.71M -43.3% Apr 1, 2016 Jun 30, 2016 10-K 2018-03-08
Q1 2016 -$74.8M -$22.1M -$10.1M -84.5% Jan 1, 2016 Mar 31, 2016 10-K 2018-03-08
Q4 2015 -$64.7M -$18.5M -$8.05M -77% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-09
Q3 2015 -$56.7M -$18.7M -$8.18M -77.5% Jul 1, 2015 Sep 30, 2015 10-K 2017-03-09
Q2 2015 -$48.5M -$15.5M -$5.38M -53.1% Apr 1, 2015 Jun 30, 2015 10-K 2017-03-09
Q1 2015 -$43.1M -$12M -$4.01M -50.2% Jan 1, 2015 Mar 31, 2015 10-K 2017-03-09
Q4 2014 -$39.1M -$10.4M -$2.56M -32.4% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-09
Q3 2014 -$36.5M -$10.5M -$1.34M -14.5% Jul 1, 2014 Sep 30, 2014 10-K 2016-03-09
Q2 2014 -$35.2M -$10.1M -$3.24M -46.9% Apr 1, 2014 Jun 30, 2014 10-K 2016-03-09
Q1 2014 -$32M -$7.98M +$27K +0.34% Jan 1, 2014 Mar 31, 2014 10-K 2016-03-09
Q4 2013 -$32M -$7.89M Oct 1, 2013 Dec 31, 2013 10-K 2015-03-11
Q3 2013 -$9.21M -$3.24M -54.4% Jul 1, 2013 Sep 30, 2013 10-K 2015-03-11
Q2 2013 -$6.9M -$2.16M -45.7% Apr 1, 2013 Jun 30, 2013 10-K 2015-03-11
Q1 2013 -$8.01M Jan 1, 2013 Mar 31, 2013 10-K 2015-03-11
Q3 2012 -$5.97M Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-12
Q2 2012 -$4.73M Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.